Castro SA

Language: Spanish
References: 5
Page: 704-707
PDF size: 501.72 Kb.

ABSTRACT

Background: Soft tissue sarcomas are a heterogeneous group of rare, solid and soft tissue cancers of mesenchymal or connective tissue origin. They can develop in almost any anatomical site, but more commonly in the extremities, trunk, viscera, retroperitoneum, or head and neck; about 10% of patients have detectable metastases at the time of diagnosis of the primary tumor, most commonly in lungs.
Clinical case: A 65-year-old female patient in whom a grade 4 undifferentiated pleomorphic sarcoma in the left atrium was diagnosed.
Conclusions: Soft tissue sarcomas require a high degree of clinical suspicion to carry out a timely multidisciplinary treatment. Having initially presented a clinical presentation that is not very suggestive of the final diagnostic result, it opens the way for expanding the differential diagnoses of this type of lineage in cardiac cavities.

REFERENCES

1. von Mehren M, Randall RL, Benjamin RS, et al. Soft tissuesarcoma, Version 2.2018, NCCN Clinical practice guidelinesin oncology. J Natl Compr Canc Netw 2018; 16 (5): 536-63.https://doi.org/doi: 10.6004/jnccn.2018.0025

2. Nystrom LM, Reimer NB, Reith JD, et al. Multidisciplinarymanagement of soft tissue sarcoma. Sci World J 2013;2013: 85246. https://doi.org/10.1155/2013/852462

3. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds.WHO Classification of tumours of soft tissue and bone. 4thed. IARC: Lyon, France; 2013.

4. Schöffski P, Cornillie J, Wozniak A, Li H, Hompes D. Softtissue sarcoma: an update on systemic treatment optionsfor patients with advanced disease. Oncol Res Treat 2014;37 (6): 355-62. http://doi.org/10.1159/000362631

5. Tyebally S, Chen D, Bhattacharyya S, et al. Cardiac Tumors:JACC CardioOncology State-of-the-Art Review. JACC CardioOncol.2020; 2 (2): 293-311. https://doi.org/10.1016/j.jaccao.2020.05.009